These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30275094)

  • 41. Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis.
    Njei B; Gupta N; Ewelukwa O; Ditah I; Foma M; Lim JK
    Liver Int; 2016 May; 36(5):634-41. PubMed ID: 26352650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B.
    Gao X; Duan X; Cai H; Hu Y; Liu M; Kang K; Zhou M; Fu D; Yi W
    Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1533-1537. PubMed ID: 31895914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Gerlich WH
    Intervirology; 2014; 57(3-4):202-11. PubMed ID: 25034489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
    Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
    Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tenofovir
    Rodríguez M; Pascasio JM; Fraga E; Fuentes J; Prieto M; Sánchez-Antolín G; Calleja JL; Molina E; García-Buey ML; Blanco MÁ; Salmerón J; Bonet ML; Pons JA; González JM; Casado MÁ; Jorquera F;
    World J Gastroenterol; 2017 Nov; 23(41):7459-7469. PubMed ID: 29151700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
    Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F
    J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.
    Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT
    Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevention of mother to child transmission of hepatitis B].
    El Agheb MO; Grange JD
    Pan Afr Med J; 2015; 20():316. PubMed ID: 26175807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate.
    Lacombe K; Gozlan J; Boelle PY; Serfaty L; Zoulim F; Valleron AJ; Girard PM
    AIDS; 2005 Jun; 19(9):907-15. PubMed ID: 15905671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate.
    Charuworn P; Hengen PN; Aguilar Schall R; Dinh P; Ge D; Corsa A; Reesink HW; Zoulim F; Kitrinos KM
    J Hepatol; 2015 May; 62(5):1033-9. PubMed ID: 25514556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B.
    Murray KF; Szenborn L; Wysocki J; Rossi S; Corsa AC; Dinh P; McHutchison J; Pang PS; Luminos LM; Pawlowska M; Mizerski J
    Hepatology; 2012 Dec; 56(6):2018-26. PubMed ID: 22544804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review.
    Bierhoff M; Smolders EJ; Tarning J; Burger DM; Spijker R; Rijken MJ; Angkurawaranon C; McGready R; White NJ; Nosten F; van Vugt M
    Antivir Ther; 2019; 24(7):529-540. PubMed ID: 31868655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus.
    Liegeon G; Ngo-Giang-Huong N; Salvadori N; Bunpo P; Cressey R; Achalapong J; Kanjanavikai P; Patamasingh Na Ayudhaya O; Prommas S; Siriwachirachai T; Sabsanong P; Yves Mary J; Jourdain G
    J Antimicrob Chemother; 2022 Mar; 77(4):1111-1118. PubMed ID: 35045168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed country.
    Sellier PO; Maylin S; Brichler S; Berçot B; Lopes A; Chopin D; Pogliaghi M; Munier AL; Delcey V; Simoneau G; Evans J; Gordien E; Simon F; Bergmann JF
    Liver Int; 2018 Apr; 38(4):611-618. PubMed ID: 28834623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
    Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
    N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
    Dore GJ; Cooper DA; Pozniak AL; DeJesus E; Zhong L; Miller MD; Lu B; Cheng AK; ;
    J Infect Dis; 2004 Apr; 189(7):1185-92. PubMed ID: 15031786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of Mother-to-Child Transmission in Patients with Chronic Hepatitis B Virus Infection and High Viral Loads.
    McCormick CA; McCormick PA
    Ir Med J; 2018 Dec; 111(10):831. PubMed ID: 30560646
    [No Abstract]   [Full Text] [Related]  

  • 59. Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
    Lee S; Ahn SH; Jung KS; Kim DY; Kim BK; Kim SU; Baatarkhuu O; Ku HJ; Han K; Park JY
    J Viral Hepat; 2017 Feb; 24(2):141-147. PubMed ID: 27766731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge].
    Yin XR; Liu ZH; Liu ZH; Li J; Zhuang H; Dou XG; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):262-265. PubMed ID: 29996336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.